Care that leaves no mark.
Theracoz builds contactless monitoring for patients too fragile to be touched.
Problem
Every year, over 13 million babies are born preterm. The smallest of them spend their first weeks in intensive care, monitored around the clock — through adhesive electrodes on skin that tears like wet paper, and wires that tangle easily.
The monitoring keeps them alive. It also injures nearly half of them, fragments the sleep their brains need to develop, and consumes a quarter of a nurse's shift.
This has been the standard of care since 1965.
Approach
We are developing a way to read the body's vital signs — heartbeat, breathing — without touching it at all. No adhesives, wires or marks.
The technology is in active development and moving toward clinical validation with Finnish university hospitals.
Origin
Theracoz was founded in 2026 in Oulu, Finland — a city that has spent fifty years teaching the world to communicate through radio waves. We are engineers from that tradition, applying it to the quietest patients there are.
Contact
If you're an investor, a clinician, or someone who wants to build this with us:
hello@theracoz.comThe future of fragile care leaves no mark.